Diabetes rates in children set to skyrocket by 2060 - study
Antonio_Diaz/iStock via Getty Images


The number of young people under age 20 in the US with type 2 diabetes could increase by up to 675% by 2060 according to a new study.
Based on data from the SEARCH for Diabetes in Youth study, the report, published in the journal Diabetes Care, found that the number of youths with type 2 diabetes will go from 28K in 2017 to 220K in 2060 if increasing trends continue.

The study noted that it is likely there will be substantial widening in incidence based on race and ethnicity, with the highest rates among Black youths.
Pharma companies in the diabetes space: Novo Nordisk (NVO), Eli Lilly (NYSE:LLY), Sanofi (SNY), Merck (NYSE:MRK), Novartis (NVS), and AstraZeneca (AZN).
Device makers in the diabetes market: Abbott (NYSE:ABT), DexCom (DXCM), Medtronic (NYSE:MDT).